+ is characteristic of thymic T cells. The DP T-PLL cells did not express TdT,CD1 or recombination activating gene-1 (RAG-1), which is down-regulated at the late stage of thymic T cell development. On the basis of these findings, we propose a late thymic origin for DP T-PLL. The phenotype of DP T cells differed for each entity and appeared to correlate with minor normal DP T cell population.
Introduction
CD4 and CD8 are key molecules in T cell differentiation and function. Expression of CD4 and CD8 is tightly regulated during T cell differentiation.
1 CD4
− CD8 − double-negative precursor T cells differentiate into CD4 +
CD8
+ double-positive (DP) thymic T cells, subsequently mature to CD4 + or CD8 + single positive T cells, and migrate to peripheral tissues. Thus, the DP phenotype is characteristic of thymic cortical T cells, though a small percentage of normal peripheral T cells are also DP. 2 Transient or persistent increases in DP-T cell numbers were recognized in patients with several diseases including viral infections and collagen diseases, and in apparently normal individuals.
3-6 DP T cell lymphocytosis appears to involve an increase in the number of activated peripheral T cells.
While CD4 is a single chain, CD8 is composed of ␣ and ␤ subunits, the expression of which are tightly regulated. [7] [8] [9] Thymic DP T cells and peripheral CD8 single-positive T cells Correspondence: M Mizuki, Department of Hematology and Oncology, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan; Fax: 81 6 879 3879 Received 1 July 1997; accepted 2 January 1998 express CD8␣␤, while CD4 single-positive T cells become DP on activation with IL-4, and the DP T cells express CD8 of ␣␣ type. 10, 11 Intestinal epithelial lymphocytes (IEL) are a distinct T cell subset, which preferentially express CD8␣␣ and contain a DP population. 12 Thus, examination of CD8 subunits is useful for the study of T cell differentiation.
Chronic T lymphoid leukemias are defined as post-thymic T cell leukemias by the FAB group, 13 and are subclassified into four entities:
LGL leukemia, ATLL, T-PLL and Sézary syndrome. The phenotype in some chronic T cell leukemias is
, DP T. [13] [14] [15] [16] [17] [18] DP T cell leukemia is rare except for T-PLL, in which the DP phenotype is relatively common. The stage of differentiation which these DP T leukemic cells represent has not been defined, though there are two hypotheses: (1) that they are thymic DP T cells, this would be unique among chronic T cell leukemias, and (2) that they are peripheral activated T cells.
In this study, we found that the phenotype of DP T cell leukemias differed for each disease entity. Comparative studies of these phenotypes with those of normal T cell populations suggested that both the above hypotheses are applicable to the different entities in chronic T cell leukemias.
Patients, materials and methods

Patients
We studied eight patients with chronic T cell leukemia. According to the FAB classification, they included two cases of LGL leukemia (patient MH and TM), three cases of ATLL (patient II, MHg and AT) and three cases of T-PLL (patient SM, RT and ST). Samples were taken from the patients after obtaining their informed consent.
Surface marker analysis
Peripheral blood mononuclear cells (PBMC) were separated from venous blood by Ficoll-Paque density gradient centrifugation. The following monoclonal antibodies (mAb), Leu-5b (CD2), Leu-4 (CD3), Leu-3a (CD4), Leu-2a (CD8␣ chain), Leu-15 (CD11b), Leu-7 (CD57), Leu-11c (CD16), Leu-19 (CD56), TCR-1 ␣␤ (antiTCR␣␤), TCR␥/␦-1 (anti-TCR␥␦), anti-IL-2R (CD25), anti-HLA-DR, Leu-6 (CD1a) and Leu-18 (CD45RA), were purchased from Becton Dickinson (Mountain View, CA, USA). All were conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE) except Leu-6. FITC-conjugated UCHL-I (CD45RO) was purchased from Dakopatts (Glostrup, Denmark). FITC-conjugated 4B4 (CD29) was purchased from Coulter Immunology (Hialeah, FL, USA). HML-1(CD103) was from Immunotech (Marseille, France). Biotinylated mAb T8/2T8-5H7 which recognizes CD8␣␤ heterodimer was kindly donated by Dr H Nakauchi (Tukuba University Medical School) and Dr EL Reinherz (Harvard Medical School).
Cells were stained by direct immunofluorescence using FITC or PE-conjugated mAbs and then, analyzed by FACScan (Becton Dickinson). Two color immunofluorescence using T8/2T8-5H7 and Leu-2a was performed as follows: cells were reacted with biotinylated T8/2T8-5H7 first, washed twice and then reacted with FITC-conjugated avidin and PE-conjugated Leu-2a. Control staining of cells was with isotype-matched monoclonal mouse immunoglobulins.
For detection of TdT, the blood films were fixed in cold methanol and stained by indirect immunofluorescence. The cells were stained with anti-TdT monoclonal antibody (Cosmo Bio, Tokyo, Japan), biotinylated anti-mouse IgG goat antibody, and FITC-streptoavidin, in that order, and examined by fluorescence microscopy.
Measurement of IL-4 production PBMC (5 × 10 5 cells) were stimulated with OKT3 alone, IL-2 alone, OKT3 and IL-2, or OKT-3, IL-2 and 12-O-tetradecanoylphorbor-13-acetate (TPA). After 3 days, the concentrations of IL-4 in the supernatants were measured using ELISA kit Quantikine IL-4 (R&D Systems, Minneapolis, MN, USA).
Detection of IL-4 and RAG-I mRNA by reversetranscriptase polymerase chain reaction method
Total cellular RNA was isolated from PBMC by the acid guanidinium thiocyanate-phenol-chloroform method. 1 g RNA was reverse-transcribed by the random primer method with Moloney murine leukemia virus reverse transcriptase. The PCR reaction (50 l) was performed under the following conditions: 30 cycles of strand separation at 94°C for 1 min, annealing at 60°C for 1 min, extension at 72°C for 2 min. IL-4 primers, RAG-I primers and actin primers were designed as follows. [19] [20] [21] IL-4A: ACTCTGTGCACCGAGTGACCGTAA Table 1 Phenotype of DP T cell leukemias Modulation of the expression of CD8 on stimulation PBMC (5 × 10 5 cells) from cases of DP-LGLL were stimulated with OKT3 × IL-4. After 3 days, the intensity of expression of the CD8 chain was examined by FACScan.
Results
Immunophenotypical features of eight patients with DP T cell leukemias are shown in Table 1 and Figure 1 . The leukemic cells from all patients expressed CD2, CD3, CD4 and CD8␣, and had TCR␣␤. On the other hand, TdT and CD1a, which are characteristic of thymic T cells, were detected in none of the cases except for weak expression of TdT in one ATLL case. RAG-1 mRNA was detected in none of eight cases studied by RT-PCR (Figure 2) .
Two LGLL cases were reactive with CD56 and CD57, three ATLL cases were reactive with CD25, and three T-PLL cases were reactive with CD7, the markers being characteristic of the diseases, respectively. We also investigated expression of CD103 antigen, a marker specific for IEL. 22 The antigen was expressed on the leukemic cells from two T-PLL cases and one ATLL case. CD45RO, preferentially expressed on memory T cells, was detected on DP T cells from five of six cases tested. One ATLL case and two T-PLL cases expressed both CD45RO and CD45RA.
Figure 1
Two color cytofluorimetric analysis of CD4 and CD8␣, and CD8␣ and CD8␤. Log green fluorescence by fluorescein isothiocyanate (FITC) is shown on the abscissa, log red fluorescence by phycoerythrin (PE) on the ordinate. Left and lower quadrant regions indicate negative controls.
Continued.
The results of two-color immunofluorescence with anti-CD4 and anti-CD8␣ or anti-CD8␣ and anti-CD8␤, are shown in Figure 1 . Two CD8␣␤ subunit structures, ␣␣ type and ␣␤ type, were distinguished in DP-T cell leukemias; all LGLL and ATLL cases showed CD8␣␣, while all T-PLL cases were of CD8␣␤ type. We recognized two patterns of CD8␣ expression: fluorescence intensity sequential from low to high, and homogeneously bright expression. We designated the former dim-positive, and the latter bright-positive. On the basis of the subunit structure and expression intensity of CD8 molecules, the cases were divided into three groups, CD8␣␣dim, CD8␣␣bright and CD8␣␤bright. Two LGLL cases and one ATLL case (MHg) showed CD8␣␣dim phenotype, and two ATLL Cases (II and AT) had CD8␣␣bright phenotype. All three T-PLL cases showed CD8␣␤bright expression.
Expression of IL-4, which was shown to induce CD8aa expression on mature CD4 + T cells, was investigated in T cell leukemias. 11 As shown in Figure 2 , IL-4 mRNA was expressed in unstimulated cells from two DP-LGLL cases. IL-4 mRNA was expressed in none of the other cases except weakly in one ATLL case (case II). As shown in Table 2 , high levels of IL-4, 751.5 and 716.4 pg/ml, were detected in the supernatant of cultured mononuclear cells (MNC) from two patients with DP-LGL leukemia, stimulated with OKT-3, IL-2 and TPA. On the other hand, there was no or slight difference in IL-4 levels between the other cases and normal individuals. IL-4 mRNA was not detected in normal PBL and the stimulators had a marginal effect on IL-4 production, indicating that the IL-4 in DP-LGLL was produced by the leukemic cells. We also examined the effect of IL-4 on the expression of CD8 in DP LGLL.
The expression was slightly increased after short-term culture with no stimulant, possibly due to the IL-4 produced by the leukemic cells, but no further up-regulation of CD8 was detected when IL-4 was added to the culture medium.
Discussion
CD4
+
, CD8
+ DP phenotype is seen in a small percentage of chronic T cell leukemias.
13-18 DP phenotype is generally regarded as characteristic of thymocytes at a certain stage of differentiation, though it is also found in some activated peripheral T cells.
2 Consistent with this finding, the DP T cells in chronic T cell leukemia are hypothesized to represent either thymic T cells, or activated peripheral T cells. In the present study, we examined phenotypical features including the subunit structure of CD8 in chronic DP T cell leukemia and investigated their correspondence to the physiologic counterpart.
Two cases of DP-LGLL showed CD8␣␣ dim phenotype. Tonutti et al 6 studied persistent expansion of DP T cells and found that 11 cases with LGL morphology expressed CD8␣␣-dim phenotype. Ortolani et al 5 described that CD4 + CD8dim + T cells in eight cases of T cell lymphocytosis expressed CD56 and CD57, characteristic of LGL. Most of these DP-T cell expansions were polyclonal. These and our findings show that CD8␣␣dim phenotype is characteristic of DP-LGL, irrespective of monoclonal or polyclonal proliferation, and suggest that these DP-LGL cells are the non-malignant counterpart of the leukemic DP-LGL. CD8␣␣ phenotype is rare among peripheral blood T cells, 
Table 2
Detection of IL-4 production but is found in certain activated T cells. Although the DP phenotype can be induced in both CD4 and CD8 single-positive T cells, DP T cells with CD8␣␣ subunit are likely to derive from CD4 + T cells, since CD8 + T cells have the ␣␤ subunit. [7] [8] [9] In fact, mature CD4 + T cells were shown to become DP by stimulation with IL-4 and to have CD4 + CD8␣␣dim phenotype, 10, 11 identical to the phenotype of DP LGLL cells. In addition, in our as well as Tonutti's cases, a significant proportion of the residual T cells other than DP T cells showed CD4
− phenotype, which also showed CD11b + , 56
+ phenotype expressed on the DP cells. These findings suggest that the DP LGLL cells are activated DP T cells that derive from mature CD4 + T cells. Therefore, we examined production of IL-4, which might contribute to induction of DP phenotype, in LGLL cells. We detected high concentrations of IL-4 in culture supernatant of mononuclear cells from two cases of DP LGLL after stimulation with anti-CD3+IL-2+TPA. Moreover, these two cases showed constitutional expression of IL-4 mRNA, which was not detected in the other DP T cell leukemias except weakly in one ATLL case. Expression of IL-4 and CD8␣␣dim phenotype appeared to be a characteristic of DP LGLL cells. Whether IL-4 expression is characteristic of non-malignant DP-LGL also, is to be examined in future.
All three cases of DP ATLL also showed CD8␣␣ phenotype. IEL is a distinct T cell subset that preferentially expresses CD8␣␣ subunits and contains a CD4 + , CD8␣␣
+ population. We investigated expression of CD103, characteristic of IEL, 22 in DP ATLL cells. The antigen was detected in only one of the DP ATLL cases, weakly, and none of the three ATLL cases showed primary involvement in the intestinal tract. Therefore, it is unlikely that the ATLL cells derive from IEL. Although DP phenotype is induced by viruses such as HHV-6, 23 HTLV-I itself does not appear to be involved in the induction of DP, since the majority of ATLL cases are CD4 single-positive.
A proportion of cases with DP T cell expansions were reported to have the CD8␣␣ phenotype and a non-LGL morphology, 6 suggesting that DP ATLL cells may also be derived from certain activated peripheral T cells. On the other hand, three DP-ATLL cases are heterogeneous in the intensity of CD8␣␣ expression and expression of IL-4 mRNA. DP phenotype is quite rare in ATLL cases, and the phenotype may reflect possible heterogeneity of the disease unified only by HTLV-I integration, or alternatively, it may result from malignant transformation. All three DP T-PLL cases showed CD4 + , CD8␣␤ + phenotype, which is different from the DP phenotype seen in LGLL and ATLL. Although DP phenotype is rare among cases of LGLL and ATLL, quite a few (21%) T-PLL cases show the phenotype. 17 This suggests that a physiologic counterpart of T-PLL cells preferentially exhibits DP phenotype, or T-PLL cells frequently have an abnormality in CD4 and CD8 expression, which arises at transition from DP to single positive. Most (75%) thymic T cells express the DP phenotype with a CD8␣␤ subunit. On the other hand, DP T cells are rare in the peripheral blood, and the CD8␣␤ phenotype is rare in DP-T cell lymphocytosis. Taken together, these findings suggest that T-PLL cases involve DP T cells at the late thymic stage.
AT the late thymic stage, TCR is rearranged and the expression of TdT and RAG-1 is down-regulated, and T cells differentiate from DP to single-positive. Thus, both CD4 and CD8 single-positive T cells are seen at this stage of development. Notably, about one-third of all T-PLL cases including DP cases express CD8, differng from ATLL and Sézary syndrome, the majority of which were CD4 single-positive. Moreover, CD7 is consistently expressed in T-PLL cells, and some T-PLL cases lack membrane CD3 and have CD3 in the cytoplasm, the phenotype being preferentially expressed in immature T cells. 1 These findings are consistent with our notion regarding a physiologic counterpart of DP T-PLL and suggest that T-PLL cells generally are less mature than other types of cells in chronic T cell leukemia.
The studies of lymphoid neoplasms provided important insights into human lymphoid differentiation. It was suggested that aberrant phenotypes in hematological malignancies are associated with neoplastic transformation, however, many of the aberrations seen in lymphoid tumors have been found to reflect heterogeneity of normal lymphocyte populations. DP-T cells are shown to occur during normal T cell differentiation and activation, and our findings suggest that DP-T leukemia cells in each disease entity may represent a normal T cell subpopulation at a different stage, respectively.
